Market Tracker

02/11 7:48am ET

Trovagene Inc (NASDAQ:TROV)

3.79
Delayed Data
As of Feb 10
 -0.08 / -2.07%
Today’s Change
2.85
Today|||52-Week Range
13.58
-29.81%
Year-to-Date

Today’s Trading

Previous close3.87
Today’s open3.94
Day’s range3.77 - 4.02
Volume358,920
Average volume (3 months)595,692
Market cap$115.0M
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-37.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales292.69
Price/Book8.77

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.06-1.32%
VCYTVeracyte Inc-0.17-3.10%
LNTHLantheus Holdings In...-0.05-2.65%
TRILTrillium Therapeutic...-0.29-3.88%
Data as of 02/10/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts